🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ASCO24 abstract titles are out! Precigen is excited to announce a late-breaking abstract for our pivotal Phase 2 study of PRGN-2012 for the treatment of patients with recurrent respiratory papillomatosis has been selected for oral presentation. bit.ly/4brTFFV $PGEN

Save-the-date: #Precigen to host conference call on June 3 to discuss the pivotal Phase 2 study data of PRGN-2012 for the treatment of RRP presented at #ASCO24 and report first quarter 2024 financial results after the market close on May 14. bit.ly/3wtWPdb $PGEN

Only 1 month to go until RRP Awareness Day, a multi-stakeholder event to raise awareness and bring together individuals living with RRP, caregivers, clinicians, and government officials. View details at rrpawareness.org and join us!

Precigen reports first quarter 2024 financial results and business updates. View press release: bit.ly/44KfgH6 $PGEN

Congratulations to #Precigen President and CEO, Helen Sabzevari, for being named as a PM360 Elite100 honoree in the Drug Researchers and Developers category. We are proud of her extraordinary leadership to advance innovative medicines. bit.ly/3WU4mNh

#Precigen to host a webcast on June 3 at 6:00 PM CT following the late-breaking oral presentation of results from the pivotal study of PRGN-2012 for the treatment of RRP at #ASCO24. View details: bit.ly/3LqNK9i $PGEN

#ASCO24: On Sunday, June 2, check out the trial-in-progress poster for Precigen's PRGN-2009 AdenoVerse Gene Therapy in HPV-associated oropharyngeal cancer (Abstract# TPS6124). bit.ly/4bGwSXk #GeneTherapy #Oncology #ClinicalTrials #OncoAlert

#ASCO24: On Monday, June 3, check out the trial-in-progress poster for Precigen's PRGN-2009 AdenoVerse Gene Therapy in recurrent or metastatic cervical cancer (Abstract # TPS5623). bit.ly/3VnqBKc #GeneTherapy #Oncology #ClinicalTrials #CervicalCancer #OncoAlert

Precigen is excited to announce pivotal study results for PRGN-2012 in RRP presented today in a late-breaking oral presentation at #ASCO24. Join us today for a live webcast with Precigen executives and study lead investigators. View data: bit.ly/3VqqRrV

Only 1 week to go until RRP Awareness Day, a multi-stakeholder event to raise awareness and bring together individuals living with RRP, caregivers, clinicians, and government officials. View details at rrpawareness.org and join us!

We had an amazing time at our inaugural #RRPAwarenessDay. Together, we are shaping a hopeful and positive future for those impacted by RRP. Watch the #RRPAwarenessDay co-hosts share their thoughts on what they hope we achieved for RRP patients today. #GivingVoicetoInspireChange

#ICYMI: Watch the replay and check out photos from the first #RRPAwarenessDay. Thank you to our patient and caregiver panelists, our co-hosts at RRPF, National Cancer Institute panelists, Mark Warner, Wes Moore and all who viewed the event! rrpawareness.org #GivingVoicetoInspireChange

Join #Precigen on Wednesday, August 14, 2024 at 4:30 PM ET for a conference call to discuss second quarter and first half 2024 financial results. View details: bit.ly/3LqNK9i $PGEN

Precigen reports second quarter / first half 2024 financial results and business updates. View press release and join our conference call today at 4:30pm ET: bit.ly/3yGJAae $PGEN